Meridian Bioscience ROA 2006-2018 | VIVO

Current and historical return on assets (ROA) values for Meridian Bioscience (VIVO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Meridian Bioscience ROA for the three months ending September 30, 2018 was 12.51%.
Meridian Bioscience ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.02B $0.00B 12.09%
2018-06-30 $0.02B $0.25B 9.50%
2018-03-31 $0.02B $0.26B 6.79%
2017-12-31 $0.02B $0.25B 8.41%
2017-09-30 $0.02B $0.25B 8.43%
2017-06-30 $0.02B $0.25B 8.01%
2017-03-31 $0.03B $0.25B 11.50%
2016-12-31 $0.03B $0.25B 11.43%
2016-09-30 $0.03B $0.25B 13.46%
2016-06-30 $0.04B $0.26B 15.87%
2016-03-31 $0.04B $0.26B 17.37%
2015-12-31 $0.04B $0.19B 19.83%
2015-09-30 $0.04B $0.18B 19.53%
2015-06-30 $0.04B $0.18B 19.69%
2015-03-31 $0.04B $0.18B 19.69%
2014-12-31 $0.04B $0.18B 19.69%
2014-09-30 $0.03B $0.18B 19.18%
2014-06-30 $0.04B $0.18B 19.75%
2014-03-31 $0.04B $0.18B 20.54%
2013-12-31 $0.04B $0.18B 20.90%
2013-09-30 $0.04B $0.18B 22.06%
2013-06-30 $0.04B $0.17B 22.60%
2013-03-31 $0.04B $0.17B 22.40%
2012-12-31 $0.04B $0.16B 22.68%
2012-09-30 $0.04B $0.16B 22.12%
2012-06-30 $0.03B $0.16B 21.05%
2012-03-31 $0.03B $0.16B 19.81%
2011-12-31 $0.03B $0.16B 17.92%
2011-09-30 $0.03B $0.16B 17.25%
2011-06-30 $0.03B $0.16B 15.97%
2011-03-31 $0.02B $0.16B 15.56%
2010-12-31 $0.02B $0.16B 15.03%
2010-09-30 $0.03B $0.16B 17.02%
2010-06-30 $0.03B $0.15B 19.61%
2010-03-31 $0.03B $0.15B 21.60%
2009-12-31 $0.03B $0.16B 22.48%
2009-09-30 $0.03B $0.16B 22.15%
2009-06-30 $0.03B $0.15B 21.84%
2009-03-31 $0.03B $0.15B 21.42%
2008-12-31 $0.03B $0.15B 21.60%
2008-09-30 $0.03B $0.15B 21.31%
2008-06-30 $0.03B $0.14B 20.36%
2008-03-31 $0.03B $0.14B 21.68%
2007-12-31 $0.03B $0.14B 21.71%
2007-09-30 $0.03B $0.13B 21.47%
2007-06-30 $0.03B $0.13B 21.18%
2007-03-31 $0.02B $0.12B 18.33%
2006-12-31 $0.02B $0.12B 17.95%
2006-09-30 $0.02B $0.12B 16.63%
2006-06-30 $0.02B $0.12B 16.11%
2006-03-31 $0.02B $0.11B 15.50%
2005-12-31 $0.01B $0.11B 14.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.823B $0.214B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00